Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
Using tissue microarrays (TMAs) we studied COX2/PPARG immunoreactivity in a broad spectrum of tumors focussing on clinicopathological correlations and the outcome of patients with malignant melanoma (MM). TMA-1 contained normal and tumor tissues (n=3448) from 47 organs including skin neoplasms (n=32...
Saved in:
Main Authors: | Stefanie Meyer, Thomas Vogt, Michael Landthaler, Anna Berand, Albrecht Reichle, Frauke Bataille, Andreas H. Marx, Anne Menz, Arndt Hartmann, Leoni A. Kunz-Schughart, Peter J. Wild |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2010/848645 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of cyclooxygenase-2 (COX-2) and inflammatory markers in the progress of Alport syndrome in Egyptian children
by: Moushira Zaki, et al.
Published: (2025-01-01) -
Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth
by: Manuel Fresno, et al.
Published: (2008-01-01) -
Cyclooxygenase-2 inhibitors: promise or peril?
by: Laurel J. Mengle-Gaw, et al.
Published: (2002-01-01) -
Cyclooxygenase-2 and its regulation in inflammation
by: Y. S. Bakhle, et al.
Published: (1996-01-01) -
Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis
by: Lei Zhao, et al.
Published: (2025-02-01)